Joêlle Simony-Lafontaine

Suggest Changes
Learn More
PURPOSE In view of the increasing number of patients treated with breast-conserving treatment (BCT) for ductal carcinoma-in-situ (DCIS), risk factors for recurrence and metastasis should be(More)